Ana
Patiño García
Consultora Investigadora
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (7)
2023
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
2019
-
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
Scientific Reports, Vol. 9, Núm. 1
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2016
-
Characterization of the antiglioma effect of the oncolytic adenovirus VCN-01
PLoS ONE, Vol. 11, Núm. 1
-
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome
Nature Communications, Vol. 7
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633
2012
-
Detectable clonal mosaicism and its relationship to aging and cancer
Nature Genetics, Vol. 44, Núm. 6, pp. 651-658